리스페리돈으로 무월경이 발생한 여자 정신분열병 환자의 우울, 불안, 삶의 질에 관한 연구
A Study on Depression, Anxiety and Quality of Life in Amenorrhea Schizophrenics Treated with Risperidone
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Abstract
Objectives：Amenorrhea, one of the most common side effects of neuroleptics, has known to be associated with prolactin elevation. Hyperprolactinemia seriously affects mental health causing depression, anxiety or hostility, while also affecting physical health causing amenorrhea, galactorrhea or sexual dysfunction. The possible correlation between risperidone-induced amenorrhea and depression, anxiety and quality of life was evaluated in a cross-sectional open study. Methods：During a five-month period, WHO quality of life-BREF (WHOQOL), Beck depression inventory (BDI) and Statetrait anxiety inventory (STAI) were applied twice at two-month intervals for 30 patients with risperidone-induced amenorrhea and 22 patients without amenorrhea. Results：Amenorrhea group had significantly higher scores in BDI and STAI-state, while showing lower scores in the quality of life than control group. The total BDI and STAI-state scores were more negatively correlated with WHOQOL score in amenorrhea group. Conclusion：Patients with risperidone-induced amenorrhea rated themselves significantly more depressed and more anxious, and a lower quality of life compared to the control group. Clinicians should be more active in evaluating and treating hyperprolactinemic side effects such as amenorrhea, galactorrhea, depression and anxiety. (J Korean Neuropsychiatr Assoc 2004; 43(5):537-545)
참고문헌 (28)
- "Chronic Mental Patients:The Qualityof Life Issue", 139, pp.1271~1276 (1982)
- "Quality of life indicators:a review of the literature", 4, pp.1~10 (1979)
- "Quality of life measurementduring antipsychotic drug therapy of schizophrenia", 22, pp.267~274 (1997)
- "The construct validity of subjective qualityof life for severly mentally ill", 183, pp.281~285 (1995)
- "The chronically mentally ill incommunity facilities.A study of quality of life", 154, pp.77~82 (1989)
- "Quality of life in schiaophrenia:Relationship to sociodemographicfactors,symptomatology and tardive dyskinesia", 94, pp.118~124 (1996)
- "Conventional versus atypicalneuroleptics:subjective quality of life in schizophrenic patients", 170, pp.422~425 (1997)
- "새로운 항정신병 약물의 부작용과 처치", pp.119~139 (1999), 중앙문화사
- "The relationship of pharmadology to side effects", 58, pp.55~62 (1997)
- "Elevated prolactinlevels in patients with schizophrenia:mechanisms and related adverseeffects", 28, pp.53~67 (2003)
- "Prolactin elevation with Antipsychotic Medications:Mechanisms pf Action and Clinical Consequences", 63, pp.56~62 (2002)
- "Prolactin,aggression and hostility:a discussion of recent studies", 2, pp.131~138 (1984)
- "Depression,hostility and anxiety in hyperprolactinemic amenorrhea", 36, pp.122~128 (1981)
- "Depressionand hostility in hyperprolactinemia", 6, pp.479~482 (1982)
- "Psychosomatic aspects of hyperprolactinemia", 40, pp.257~262
- "The psychobiology of menstrual dysphoria:therole of prolactin", 3, pp.171~180 (1978)
- "The diagnostic and statistical manualof mental disorder" (1994), American PsychiatricPress
- "The positive and negative syndromescale(PANSS)for schizophrenia", 2, pp.261~276 (1987)
- "The UKUside effect rating scale", 76(334), pp.1~100 (1987)
- "BDI,SDS,MMPI-D 척도의 신뢰도 및 타당도에대한 연구", 10, pp.98~113 (1991)
- , 1978, ~, pp.고려대학교
- "한국판 세계보건기구삶의 질 간편형 척도(WHOQOL-BREF)의 개발", 39, pp.571~579 (2000)
- "Distress in hyperprolactinemia" (1983)
- "Psychological distress in hyperprolactinemic women", pp.601~668 (1985), Liviana Press
- "Risperidone in the treatment of patients with chronic schizophrenia:A multi-national, multi-centre, double-blind, parallel-groupstudy versus haloperidol", 166, pp.712~733 (1995)
- "Suicidal behavior in schizophrenics Depression in Schizophrenics", pp.137~152 (1989), Plenum Publishing
- "Quality of life in the evaluation of communitysupport systems", 5, pp.69~79 (1982)
- "Atypical antipsychotic drugs andlong-term outcome in schizophrenia", 57, pp.53~60 (1996)